Sponsors (2)
Official title: To require enforcement against misbranded egg alternatives.
Introduced September 30, 2025 by Elise M. Stefanik · Last progress September 30, 2025
The bill improves consumer protection and allergen safety by requiring uniform federal definitions and clearer labeling for 'egg' products, but does so at the cost of compliance burdens, potential enforcement actions, and reduced market access and choice (and possible price increases) for plant‑based and small producers.
Consumers (and small businesses) gain clearer, nationwide labeling rules that prevent non‑egg products from using 'egg' market names, reducing consumer confusion about product contents.
People with egg allergies (and other concerned consumers) can more reliably avoid products that contain real eggs because stricter definitions and labeling improve allergen transparency.
Producers, manufacturers, and consumers benefit from federal, uniform regulatory clarity (FDA guidance and a nationwide prohibition on misuse of 'egg' names), reducing state-by-state enforcement uncertainty.
Small manufacturers, plant‑based producers, distributors, and retailers will face substantial compliance costs (reformulation, relabeling) and potential enforcement actions during transition, imposing financial strain especially on smaller firms.
People who avoid eggs for dietary, ethical, or allergy reasons may see fewer product choices or loss of familiar plant‑based 'egg' alternatives as some items are removed from interstate shelves or rebranded, reducing market availability and consumer choice.
Low‑income consumers could face higher prices if added compliance costs for alternative‑protein producers are passed through, making some affordable alternatives more expensive.
Based on analysis of 4 sections of legislative text.
Prohibits using egg or egg-product market names in interstate commerce unless the product meets a new statutory definition and requires FDA guidance and reporting.
Prohibits foods from using an egg or egg-product market name in interstate commerce unless the food meets a new statutory definition of “egg” or “egg product.” It adds a new misbranding provision to the Federal Food, Drug, and Cosmetic Act that ties unlawful labeling to a biological/regulatory definition of eggs and egg products, requires FDA guidance on enforcement within 1 year, and requires a report to Congress within 2 years describing enforcement actions and next steps if misbranded products remain on the market.